Company: IR
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001628280-25-047838
Chunk: 62

Company: Ingersoll Rand Inc.
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 1
Chunk 62
---
 the nine month period ended September 30, 2025 compared to net income of $614.4 million in the same nine month period in 2024. The decrease in net income was primarily due to impairments of goodwill and other intangible assets and the impairment of an equity method investment in the second quarter of 2025.

Adjusted EBITDA

Adjusted EBITDA increased $11.9 million to $544.6 million for the three month period ended September 30, 2025 compared to $532.7 million in the same three month period in 2024. Adjusted EBITDA as a percentage of revenues decreased 70 basis points to 27.9% for the three month period ended September 30, 2025 from 28.6% for the same three month period in 2024. The increase in Adjusted EBITDA was primarily due to higher pricing of $49.4 million, acquisitions of $19.3 million, and the favorable impact of foreign currencies of $8.0 million, partially offset by lower organic sales volume of $32.6 million, unfavorable cost 

43

productivity and product mix of $25.4 million, and higher selling and administrative costs of $6.4 million. The decrease in Adjusted EBITDA as a percentage of revenues is primarily attributable to unfavorable cost leverage on lower organic volumes, tariff related pricing targeted to offset tariff cost increases one for one, and the decretive impact of acquisitions.

Adjusted EBITDA increased $27.9 million to $1,513.7 million for the nine month period ended September 30, 2025 compared to $1,485.8 million in the same nine month period in 2024. Adjusted EBITDA as a percentage of revenues decreased 60 basis points to 27.2% for the nine month period ended September 30, 2025 from 27.8% for the same nine month period in 2024. The increase in Adjusted EBITDA was primarily due to higher pricing of $106.3 million, acquisitions of $76.5 million, lower selling and administrative costs of $2.5 million, and the favorable impact of foreign currencies of $8.7 million, partially offset by lower organic sales volume of $114.6 million and unfavorable cost productivity and product mix of $51.1 million. The decrease in Adjusted EBITDA as a percentage of revenues is primarily attributable to unfavorable cost leverage on